Benign Infantile Epilepsy Gene Panel
Understanding Benign Infantile Epilepsy Genetic Testing
The Benign Infantile Epilepsy Gene Panel represents a breakthrough in pediatric neurology diagnostics, offering comprehensive genetic analysis for infants experiencing seizure disorders. This advanced Next-Generation Sequencing (NGS) test examines multiple genes simultaneously to identify mutations associated with benign infantile epilepsy syndromes. Early genetic diagnosis is crucial for proper management, treatment planning, and providing families with accurate prognostic information.
What Does This Test Detect?
Our comprehensive gene panel analyzes multiple genetic markers associated with benign infantile epilepsy syndromes, including:
- PRRT2 gene mutations – the most common cause of benign familial infantile epilepsy
- SCN2A gene variants associated with benign familial neonatal-infantile seizures
- KCNQ2 and KCNQ3 mutations linked to benign neonatal seizures
- Other genetic markers associated with self-limiting seizure disorders in infancy
The test utilizes state-of-the-art NGS technology to provide comprehensive coverage of relevant genetic regions, ensuring high detection rates for both common and rare mutations.
Who Should Consider This Genetic Test?
This specialized genetic panel is recommended for infants and children presenting with:
- Recurrent seizures beginning in the first year of life
- Family history of benign infantile epilepsy or seizure disorders
- Seizures that occur in clusters or brief episodes
- Normal development between seizure episodes
- Absence of structural brain abnormalities on imaging
- Seizures that respond well to standard anti-epileptic medications
Key Benefits of Genetic Testing
Undergoing the Benign Infantile Epilepsy Gene Panel offers numerous advantages:
- Accurate Diagnosis: Differentiate between benign and more severe epilepsy syndromes
- Treatment Guidance: Inform medication selection and management strategies
- Prognostic Information: Provide families with realistic expectations about seizure resolution
- Family Planning: Understand inheritance patterns and recurrence risks
- Early Intervention: Enable timely management and reduce unnecessary treatments
- Peace of Mind: Reduce diagnostic uncertainty and anxiety for families
Understanding Your Test Results
Our comprehensive genetic report provides detailed analysis and interpretation:
- Positive Result: Identifies specific genetic mutations, confirming diagnosis and guiding management
- Negative Result: Does not completely rule out genetic causes but suggests other diagnostic considerations
- Variant of Uncertain Significance: Identifies genetic changes requiring further clinical correlation
- Carrier Status: May identify parents as carriers of recessive conditions
All results are accompanied by detailed genetic counseling recommendations and clinical correlation guidance.
Test Pricing Information
| Test Component | Price (USD) |
|---|---|
| Discount Price | $900 |
| Regular Price | $1200 |
Nationwide Testing Availability
We have diagnostic centers conveniently located across the United States, including major metropolitan areas such as New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our network of certified genetic counselors and neurologists ensures comprehensive care regardless of your location.
Schedule Your Genetic Consultation Today
Take the first step toward understanding your child’s seizure disorder. Our team of genetic specialists and pediatric neurologists is ready to provide comprehensive evaluation and testing. Contact us today to schedule your appointment and discuss whether the Benign Infantile Epilepsy Gene Panel is right for your family.
Call or WhatsApp: +1(267) 388-9828 to book your genetic testing appointment. Our genetic counseling team is available to answer your questions and guide you through the testing process.